Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision
1 other identifier
interventional
40
1 country
1
Brief Summary
phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 21, 2021
CompletedFirst Posted
Study publicly available on registry
May 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2021
CompletedMay 27, 2021
May 1, 2021
9 months
May 21, 2021
May 25, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
intermediate vision assessment
Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 80 cm .
6 months postoperatively
near vision assessment
Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 40 cm.
6 months postoperatively
Secondary Outcomes (1)
defocus curve
6 months postoperatively
Study Arms (1)
Assessment of intermediate vision, defocus curve
OTHERStandardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 4 m, 80 cm, and 40 cm. he binocular defocus curve: The binocular defocus curve was done to evaluate the functional range of vision. The curve was obtained while the patient wearing his distance correction to provide the best distance visual acuity in both eyes. The test was performed under photopic conditions (85 candelas/m2) using ETDRS charts at a distance of 4m with the introduction of defocusing lenses from +1.00 D to -4.00 D in 0.50 D steps.
Interventions
phacoemulsification with implantation of EYEHANCE IOL
Eligibility Criteria
You may qualify if:
- normal ocular examination apart from cataract.
You may not qualify if:
- previous ocular surgery.
- ocular pathology or corneal abnormalities.
- endothelial cell count below 2000 cells/mm2.
- corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Daralshifa hospital
Kuwait City, Kuwait
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- catract and refractive surgery specialist
Study Record Dates
First Submitted
May 21, 2021
First Posted
May 27, 2021
Study Start
November 1, 2020
Primary Completion
July 30, 2021
Study Completion
October 30, 2021
Last Updated
May 27, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share